| Product Code: ETC9550257 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Bradykinin Mediated Angioedema Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Bradykinin Mediated Angioedema Market - Industry Life Cycle |
3.4 Sweden Bradykinin Mediated Angioedema Market - Porter's Five Forces |
3.5 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.7 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Bradykinin Mediated Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about bradykinin-mediated angioedema and its treatment options |
4.2.2 Growing prevalence of bradykinin-mediated angioedema in Sweden |
4.2.3 Technological advancements in diagnostic tools and treatment options for the condition |
4.3 Market Restraints |
4.3.1 High cost associated with the treatment of bradykinin-mediated angioedema |
4.3.2 Limited availability of specialized healthcare professionals for the management of the condition |
4.3.3 Regulatory challenges in the approval and reimbursement of new treatment options |
5 Sweden Bradykinin Mediated Angioedema Market Trends |
6 Sweden Bradykinin Mediated Angioedema Market, By Types |
6.1 Sweden Bradykinin Mediated Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By C1-INH Concentrates, 2021- 2031F |
6.1.4 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Bradykinin B2-Receptor Antagonist, 2021- 2031F |
6.1.5 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Icatibant, 2021- 2031F |
6.1.6 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.7 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Ecallantide, 2021- 2031F |
6.1.8 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Bradykinin Mediated Angioedema Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.3 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Bradykinin Mediated Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4 Sweden Bradykinin Mediated Angioedema Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Sweden Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Bradykinin Mediated Angioedema Market Import-Export Trade Statistics |
7.1 Sweden Bradykinin Mediated Angioedema Market Export to Major Countries |
7.2 Sweden Bradykinin Mediated Angioedema Market Imports from Major Countries |
8 Sweden Bradykinin Mediated Angioedema Market Key Performance Indicators |
8.1 Average time from symptom onset to treatment initiation |
8.2 Patient adherence to prescribed treatment regimens |
8.3 Number of healthcare facilities offering specialized care for bradykinin-mediated angioedema |
9 Sweden Bradykinin Mediated Angioedema Market - Opportunity Assessment |
9.1 Sweden Bradykinin Mediated Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Sweden Bradykinin Mediated Angioedema Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.3 Sweden Bradykinin Mediated Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Sweden Bradykinin Mediated Angioedema Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Bradykinin Mediated Angioedema Market - Competitive Landscape |
10.1 Sweden Bradykinin Mediated Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Sweden Bradykinin Mediated Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here